Haxone-T 1.125gm Injection
By Haxone-T
Rx
1 Injection in a Vial

Composition
Ceftriaxone(1000mg) + Tazobactum(125mg)

Manufacturer - Hiya Lifesciences Pvt Ltd
SCO 42, 1st Floor, Swastic Vihar, Mansa Devi Complex, Sector 5, Panchkula, Haryana 134109, India

Expires on or after
July, 2025

liver
When using Haxone-T 1.125gm Injection, it's important to be cautious if you have severe liver disease. In such cases, the dosage of Haxone-T 1.125gm Injection may need to be adjusted. It's crucial to consult your doctor before starting treatment with Haxone-T 1.125gm Injection if you have severe liver disease. However, if you have mild to moderate liver disease, dose adjustment of Haxone-T 1.125gm Injection is not typically recommended. Always follow your doctor's guidance and advice regarding the use of Haxone-T 1.125gm Injection in relation to your liver health.

kidney
Limited data exists on the use of Haxone-T 1.125gm Injection in people with kidney issues. It's recommended to seek advice from your doctor.

alcohol
When taking Haxone-T 1.125gm Injection, it is safe to consume alcohol as it does not lead to any harmful effects.

driving
Haxone-T 1.125gm Injection may reduce alertness and cause drowsiness or dizziness. It is advised not to drive if experiencing these symptoms.

pregnancy
Haxone-T 1.125gm Injection is generally safe during pregnancy. Animal studies show minimal harm to the baby, but human studies are limited.

breastfeeding
Haxone-T 1.125gm Injection should be used cautiously while breastfeeding. It is advised to temporarily stop breastfeeding until the mother's treatment is finished and the medicine is cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹130
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024